Comparison of Safety and Efficacy Between Dabigatran and Rivaroxaban in Nonvalvular Atrial Fibrillation in Tertiary Level Hospital. Univ. Heart J. 2022, 18 (1), 10-13. https://doi.org/10.3329/uhj.v18i1.57874.